![]() | ||
4.06.2016 | AGENDA | |
. | ||
12:30 – 1:30 | Registration & Networking | |
1:30 – 1:45 | Welcome & Opening Remarks Al Sandrock, Chief Medical Officer, Biogen Bob Buderi, Founder, CEO, and Editor in Chief, Xconomy | |
1:45 – 2:15 | Neoantigens and the Next Wave of Cancer Vaccines Cary Pfeffer, Partner, Third Rock Ventures Nir Hacohen, Co-founder, Neon Therapeutics; Director, MGH Center for Immunotherapy Samantha Singer, COO, The Broad Institute (moderator) | |
2:15 – 2:30 | Spotlight Talk: Biotech Game Theory Peter Kolchinsky, Founder & Managing Director, RA Capital | |
2:30 – 3:00 | Innovative Approaches to Neuroscience Deborah Dunsire, CEO, Forum Pharmaceuticals Al Sandrock, Chief Medical Officer, Biogen Daphne Zohar, CEO, PureTech Health Jens Eckstein, President, SR One (moderator) | |
3:00 – 3:30 | Networking Break | |
3:30 – 4:00 | NASH and Nimbus: Combating the Looming Liver Disease Epidemic Bruce Booth, Partner, Atlas Venture Don Nicholson, CEO, Nimbus Therapeutics | |
4:00 – 4:15 | Spotlight Talk: The Druggability Gap Gregory Verdine, Founder & CSO, Warp Drive Bio; Professor, Harvard University | |
4:15 – 4:45 | Biology Meets Engineering Phillip A. Sharp, Nobel Laureate; Institute Professor, MIT Robert Urban, Head, Johnson & Johnson Innovation, Boston (moderator) | |
4:45 – 5:15 | Drug Pricing and Innovation: Combating Healthcare’s Biggest Challenge Peter Hecht, CEO, Ironwood Pharmaceuticals Tillman U. Gerngross, Professor of Bioengineering, Dartmouth College Marc Rubenstein, Partner, Ropes & Gray (moderator) | |
5:15 – 6:30 | Networking Reception |
*Schedule is subject to change.
Join us on April 6, register now.